Prospective Multicenter, Clinical Trial of HIV+ Deceased Donor Liver Transplants for HIV+ Recipients
Sponsor: |
NIAID |
Enrolling: |
Male and Female Patients |
IRB Number: |
AAAS2561 |
U.S. Govt. ID: |
NCT03734393 |
Contact: |
Marcus Pereira, MD, MPH: 212-305-3839 / mp2323@cumc.columbia.edu |
The primary objective of this study is to determine if an HIV-infected donor liver (HIVD+) transplant is safe with regards to major transplant-related and HIV-related complications. This study will evaluate if receiving a liver transplant from an HIV-infected deceased liver donor is safe with regards to survival and major transplant-related and HIV-related complications compared to receiving a liver from an HIV-uninfected deceased liver donor (HIVD-). Those participants who have accepted a HIVD- organ will be randomized to be followed in the full study or followed in the nested observational group.
This study is closed
Investigator
Marcus Pereira, MD, MPH
Are you 18 years of age or older? |
Yes |
No |
Are you HIV-positive? |
Yes |
No |
Are you eligible for a liver transplant? |
Yes |
No |